Last Close
522.25 $
Jul 7, 26
Market Cap
133.9 B $
Q1 2026 (TTM)
52-Week Range
%+13.7
%34.8
-0.60
-0.55
%-1.4
-%23.6
1M
+16.9%
3M
+20.9%
6M
+11.5%
YTD
+15.2%
1Y
+13.7%
3Y
+54.4%
Returns are computed from split-adjusted closes; dividends are not included.
Stock and gold/silver returns are in USD (metals converted into the stock's currency). The S&P 500 index is measured in its own currency.
VRTX last closed at 522.25 $ (Jul 7, 26). Price data is refreshed after every trading day.
Vertex Pharmaceuticals Inc trades at a trailing-twelve-month P/E of 30.85. See the comparison tables on the Peers tab for the industry context.
Vertex Pharmaceuticals Inc (VRTX) has a market capitalization of approximately 133.9 B $ as of the latest reported period.
Key peers of Vertex Pharmaceuticals Inc include CSL Ltd, TELIX Pharmaceuticals Ltd. A detailed metric comparison is available on the Peers tab.
Data on this page refreshes once per day. Price data as of Jul 7, 26. This content is for informational purposes only and is not investment advice.